Hirai et al., 1983 - Google Patents
Isolation and partial purification of a new class of transforming growth factors from an avian sarcoma virus-transformed rat cell lineHirai et al., 1983
- Document ID
- 8993043067676216959
- Author
- Hirai R
- Yamaoka K
- Mitsui H
- Publication year
- Publication venue
- Cancer Research
External Links
Snippet
Transformation of rat cells by avian sarcoma viruses induced the release of growth factors into serum-free conditioned medium. An avian sarcoma virus-transformed rat cell line, 77N1, produced and released a polypeptide growth factor, classified as a transforming growth …
- 102000009618 Transforming Growth Factors 0 title abstract description 89
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Proper et al. | Mouse embryos contain polypeptide growth factor (s) capable of inducing a reversible neoplastic phenotype in nontransformed cells in culture | |
Grey et al. | Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts. | |
Todaro et al. | Growth factors produced by sarcoma virus-transformed cells | |
Nickell et al. | Transforming growth factors in solid human malignant neoplasms | |
Lemke et al. | Identification and purification of glial growth factor | |
Feramisco et al. | Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells | |
Carr et al. | Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type β transforming growth factor | |
Connolly et al. | Human vascular permeability factor: isolation from U937 cells | |
Zwiebel et al. | Partial purification of transforming growth factors from human milk | |
CN1318084C (en) | Neuroprotective peptides | |
Morgan et al. | Tubulin constancy during morphological differentiation of mouse neuroblastoma cells. | |
Hirai et al. | Isolation and partial purification of a new class of transforming growth factors from an avian sarcoma virus-transformed rat cell line | |
WO1993018147A1 (en) | Protein compound capable of inhibiting tumoral growth | |
Alter et al. | Globin synthesis in mouse erythroleukemia cells in vitro: a switch in beta chains due to inducing agent | |
Westphal et al. | Epidermal growth factor—receptors on cultured human meningioma cells | |
CN101190944A (en) | Human cytokine and use thereof | |
Yamaoka et al. | The purification of an acid‐and heat‐labile transforming growth factor from an avian sarcoma virus‐transformed rat cell line | |
CN1017626B (en) | Growth resulating factor for new cell | |
Rossi et al. | Expression in murine and human neuroblastoma cell lines of VGF, a tissue specific protein | |
Bradley et al. | Factors determining colony forming efficiency in agar suspension cultures. | |
Loeb et al. | Comparison of chromosomal proteins of mouse primitive teratocarcinoma, liver and L cells | |
Sullivan et al. | Microinjection of the ras oncogene protein into nonestablished rat embryo fibroblasts | |
Ove et al. | Isolation of an autocrine growth factor from hepatoma HTC‐SR cells | |
Goeken et al. | Immunosuppressive activity of isolated rat and human fetoproteins | |
CA1295241C (en) | Lymphokine and its production and uses |